Sector Gamma AS’s Ascendis Pharma A/S ASND Stock Holding History

Sector Gamma AS’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.68M	Hold	21,305	–	–	1.23%	28
2026 Q1	$4.87M	Buy	21,305 +5,000	+31%	+$1.12M	1.15%	30
2025 Q4	$3.48M	Sell	16,305 -8,022	-33%	-$1.66M	0.79%	33
2025 Q3	$4.84M	Buy	24,327 +7,327	+43%	+$1.37M	1.2%	30
2025 Q2	$2.93M	Hold	17,000	–	–	0.96%	35
2025 Q1	$2.65M	Buy	+17,000	New	+$2.43M	0.85%	28

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sector Gamma AS's ASND Position: Q2 2026 in Review

Sector Gamma AS held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 21,305 shares worth $5.68M. The position accounts for 1.23% of the portfolio, ranked #28.

Sector Gamma AS first reported a position in ASND in Q1 2025 and has held it in 6 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Sector Gamma AS held 21,305 shares of Ascendis Pharma A/S worth $5.68M as of Q2 2026.
Sector Gamma AS left its Ascendis Pharma A/S share count unchanged in Q2 2026.
Ascendis Pharma A/S made up 1.23% of Sector Gamma AS's portfolio in Q2 2026, its #28 holding.
Sector Gamma AS first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 6 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.